164 related articles for article (PubMed ID: 30896531)
1. Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery Outcomes.
Pantziarka P; Bouche G
Cancer J; 2019; 25(2):100-105. PubMed ID: 30896531
[TBL] [Abstract][Full Text] [Related]
2. Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugs.
Pantziarka P; Bouche G; Sullivan R; Ilbawi AM; Dare AJ; Meheus L
Eur J Surg Oncol; 2017 Nov; 43(11):1985-1988. PubMed ID: 28928011
[TBL] [Abstract][Full Text] [Related]
3. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
4. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and consensus definitions for standardised endpoints in perioperative medicine: postoperative cancer outcomes.
Buggy DJ; Freeman J; Johnson MZ; Leslie K; Riedel B; Sessler DI; Kurz A; Gottumukkala V; Short T; Pace N; Myles PS;
Br J Anaesth; 2018 Jul; 121(1):38-44. PubMed ID: 29935592
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
[TBL] [Abstract][Full Text] [Related]
7. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
8. Perioperative interventions in pelvic organ prolapse surgery.
Haya N; Feiner B; Baessler K; Christmann-Schmid C; Maher C
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013105. PubMed ID: 30121957
[TBL] [Abstract][Full Text] [Related]
9. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
10. Understanding clinical strategies that may impact tumour growth and metastatic spread at the time of cancer surgery.
Hiller J; Brodner G; Gottschalk A
Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):427-39. PubMed ID: 24267549
[TBL] [Abstract][Full Text] [Related]
11. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review.
Wall T; Sherwin A; Ma D; Buggy DJ
Br J Anaesth; 2019 Aug; 123(2):135-150. PubMed ID: 31255291
[TBL] [Abstract][Full Text] [Related]
12. Old wine in new bottles: Drug repurposing in oncology.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
[TBL] [Abstract][Full Text] [Related]
13. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
14. Challenges in research related to perioperative cancer care and cancer outcomes.
Cata JP; Kurz A
Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):457-64. PubMed ID: 24267551
[TBL] [Abstract][Full Text] [Related]
15. Perioperative events influence cancer recurrence risk after surgery.
Hiller JG; Perry NJ; Poulogiannis G; Riedel B; Sloan EK
Nat Rev Clin Oncol; 2018 Apr; 15(4):205-218. PubMed ID: 29283170
[TBL] [Abstract][Full Text] [Related]
16. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
17. Perioperative therapies for urological cancers.
Inokuchi J; Yokomizo A; Nishiyama N; Kitamura H; Eto M; Nishiyama H; Tomita Y
Jpn J Clin Oncol; 2020 Apr; 50(4):357-367. PubMed ID: 32115649
[TBL] [Abstract][Full Text] [Related]
18. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
19. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to perioperative assessment and intervention may improve long-term outcomes after colorectal cancer resection in older adults.
Cheema FN; Abraham NS; Berger DH; Albo D; Taffet GE; Naik AD
Ann Surg; 2011 May; 253(5):867-74. PubMed ID: 21183846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
